Literature DB >> 26713745

The role of microglia and macrophages in glioma maintenance and progression.

Dolores Hambardzumyan1, David H Gutmann2, Helmut Kettenmann3.   

Abstract

There is a growing recognition that gliomas are complex tumors composed of neoplastic and non-neoplastic cells, which each individually contribute to cancer formation, progression and response to treatment. The majority of the non-neoplastic cells are tumor-associated macrophages (TAMs), either of peripheral origin or representing brain-intrinsic microglia, that create a supportive stroma for neoplastic cell expansion and invasion. TAMs are recruited to the glioma environment, have immune functions, and can release a wide array of growth factors and cytokines in response to those factors produced by cancer cells. In this manner, TAMs facilitate tumor proliferation, survival and migration. Through such iterative interactions, a unique tumor ecosystem is established, which offers new opportunities for therapeutic targeting.

Entities:  

Mesh:

Year:  2016        PMID: 26713745      PMCID: PMC4876023          DOI: 10.1038/nn.4185

Source DB:  PubMed          Journal:  Nat Neurosci        ISSN: 1097-6256            Impact factor:   24.884


  95 in total

1.  Targeting gene-modified hematopoietic cells to the central nervous system: use of green fluorescent protein uncovers microglial engraftment.

Authors:  J Priller; A Flügel; T Wehner; M Boentert; C A Haas; M Prinz; F Fernández-Klett; K Prass; I Bechmann; B A de Boer; M Frotscher; G W Kreutzberg; D A Persons; U Dirnagl
Journal:  Nat Med       Date:  2001-12       Impact factor: 53.440

2.  Microglia isolated from patients with glioma gain antitumor activities on poly (I:C) stimulation.

Authors:  Tim Kees; Jennifer Lohr; Johannes Noack; Rodrigo Mora; Georg Gdynia; Grischa Tödt; Aurélie Ernst; Bernhard Radlwimmer; Christine S Falk; Christel Herold-Mende; Anne Régnier-Vigouroux
Journal:  Neuro Oncol       Date:  2011-10-20       Impact factor: 12.300

3.  Dopamine induces growth inhibition and vascular normalization through reprogramming M2-polarized macrophages in rat C6 glioma.

Authors:  Tian Qin; Chenlong Wang; Xuewei Chen; Chenfan Duan; Xiaoyan Zhang; Jing Zhang; Hongyan Chai; Tian Tang; Honglei Chen; Jiang Yue; Ying Li; Jing Yang
Journal:  Toxicol Appl Pharmacol       Date:  2015-03-25       Impact factor: 4.219

4.  Fate mapping reveals origins and dynamics of monocytes and tissue macrophages under homeostasis.

Authors:  Simon Yona; Ki-Wook Kim; Yochai Wolf; Alexander Mildner; Diana Varol; Michal Breker; Dalit Strauss-Ayali; Sergey Viukov; Martin Guilliams; Alexander Misharin; David A Hume; Harris Perlman; Bernard Malissen; Elazar Zelzer; Steffen Jung
Journal:  Immunity       Date:  2012-12-27       Impact factor: 31.745

5.  A dialog between glioma and microglia that promotes tumor invasiveness through the CCL2/CCR2/interleukin-6 axis.

Authors:  Jing Zhang; Susobhan Sarkar; Rowena Cua; Yan Zhou; Walter Hader; V Wee Yong
Journal:  Carcinogenesis       Date:  2011-12-08       Impact factor: 4.944

6.  In vitro modulation of microglia motility by glioma cells is mediated by hepatocyte growth factor/scatter factor.

Authors:  B Badie; J Schartner; J Klaver; J Vorpahl
Journal:  Neurosurgery       Date:  1999-05       Impact factor: 4.654

7.  Optic gliomas in children with neurofibromatosis type 1.

Authors:  R Listernick; J Charrow; M J Greenwald; N B Esterly
Journal:  J Pediatr       Date:  1989-05       Impact factor: 4.406

8.  Monocyte chemoattractant protein-1 increases microglial infiltration and aggressiveness of gliomas.

Authors:  Michael Platten; Alexandra Kretz; Ulrike Naumann; Steffen Aulwurm; Kensuke Egashira; Stefan Isenmann; Michael Weller
Journal:  Ann Neurol       Date:  2003-09       Impact factor: 10.422

9.  Possible involvement of the M2 anti-inflammatory macrophage phenotype in growth of human gliomas.

Authors:  Y Komohara; K Ohnishi; J Kuratsu; M Takeya
Journal:  J Pathol       Date:  2008-09       Impact factor: 7.996

10.  F11R is a novel monocyte prognostic biomarker for malignant glioma.

Authors:  Winnie W Pong; Jason Walker; Todd Wylie; Vincent Magrini; Jingqin Luo; Ryan J Emnett; Jaebok Choi; Matthew L Cooper; Malachi Griffith; Obi L Griffith; Joshua B Rubin; Gregory N Fuller; David Piwnica-Worms; Xi Feng; Dolores Hambardzumyan; John F DiPersio; Elaine R Mardis; David H Gutmann
Journal:  PLoS One       Date:  2013-10-11       Impact factor: 3.240

View more
  523 in total

Review 1.  The Gut-Brain Axis, Paving the Way to Brain Cancer.

Authors:  Ruty Mehrian-Shai; Juergen K V Reichardt; Curtis C Harris; Amos Toren
Journal:  Trends Cancer       Date:  2019-03-16

Review 2.  Glioblastoma niches: from the concept to the phenotypical reality.

Authors:  Davide Schiffer; Marta Mellai; Enrica Bovio; Ilaria Bisogno; Cristina Casalone; Laura Annovazzi
Journal:  Neurol Sci       Date:  2018-05-08       Impact factor: 3.307

3.  Intravital 2-photon imaging reveals distinct morphology and infiltrative properties of glioblastoma-associated macrophages.

Authors:  Zhihong Chen; James L Ross; Dolores Hambardzumyan
Journal:  Proc Natl Acad Sci U S A       Date:  2019-06-24       Impact factor: 11.205

Review 4.  Brain Tumor Microenvironment and Host State: Implications for Immunotherapy.

Authors:  William Tomaszewski; Luis Sanchez-Perez; Thomas F Gajewski; John H Sampson
Journal:  Clin Cancer Res       Date:  2019-02-25       Impact factor: 12.531

5.  Glioma escape signature and clonal development under immune pressure.

Authors:  Cecile L Maire; Malte Mohme; Michael Bockmayr; Krystian D Fita; Kristoffer Riecken; Daniela Börnigen; Malik Alawi; Antonio Failla; Katharina Kolbe; Svenja Zapf; Mareike Holz; Katrin Neumann; Lasse Dührsen; Tobias Lange; Boris Fehse; Manfred Westphal; Katrin Lamszus
Journal:  J Clin Invest       Date:  2020-10-01       Impact factor: 14.808

Review 6.  Therapeutic dormancy to delay postsurgical glioma recurrence: the past, present and promise of focal hypothermia.

Authors:  Didier Wion
Journal:  J Neurooncol       Date:  2017-05-17       Impact factor: 4.130

7.  EGFRvIII-Stat5 Signaling Enhances Glioblastoma Cell Migration and Survival.

Authors:  Alison Roos; Harshil D Dhruv; Sen Peng; Landon J Inge; Serdar Tuncali; Michael Pineda; Nghia Millard; Zachary Mayo; Jennifer M Eschbacher; Joseph C Loftus; Jeffrey A Winkles; Nhan L Tran
Journal:  Mol Cancer Res       Date:  2018-05-03       Impact factor: 5.852

8.  Immune heterogeneity and clinicopathologic characterization of IGFBP2 in 2447 glioma samples.

Authors:  Jinquan Cai; Qun Chen; Yuqiong Cui; Jiawei Dong; Meng Chen; Pengfei Wu; Chuanlu Jiang
Journal:  Oncoimmunology       Date:  2018-02-13       Impact factor: 8.110

9.  Dynamic interplay between tumour, stroma and immune system can drive or prevent tumour progression.

Authors:  R J Seager; Cynthia Hajal; Fabian Spill; Roger D Kamm; Muhammad H Zaman
Journal:  Converg Sci Phys Oncol       Date:  2017-07-28

10.  Pretreatment with Korean red ginseng or dimethyl fumarate attenuates reactive gliosis and confers sustained neuroprotection against cerebral hypoxic-ischemic damage by an Nrf2-dependent mechanism.

Authors:  Lei Liu; Mary K Vollmer; Abdullah S Ahmad; Victoria M Fernandez; Hocheol Kim; Sylvain Doré
Journal:  Free Radic Biol Med       Date:  2018-11-17       Impact factor: 7.376

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.